| Year |
Citation |
Score |
| 2010 |
Lameh J, Bertozzi F, Kelly N, Jacobi PM, Nguyen D, Bajpai A, Gaubert G, Olsson R, Gardell LR. Neuropeptide FF receptors have opposing modulatory effects on nociception. The Journal of Pharmacology and Experimental Therapeutics. 334: 244-54. PMID 20354177 DOI: 10.1124/jpet.109.164384 |
0.501 |
|
| 2008 |
Fioravanti B, De Felice M, Stucky CL, Medler KA, Luo MC, Gardell LR, Ibrahim M, Malan TP, Yamamura HI, Ossipov MH, King T, Lai J, Porreca F, Vanderah TW. Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 11593-602. PMID 18987195 DOI: 10.1523/Jneurosci.3322-08.2008 |
0.715 |
|
| 2008 |
Gardell LR, Hyldtoft L, Del Tredici AL, Andersen CB, Fairbairn LC, Lund BW, Gustafsson M, Brann MR, Olsson R, Piu F. Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist. European Journal of Pharmacology. 592: 158-9. PMID 18644363 DOI: 10.1016/j.ejphar.2008.06.107 |
0.408 |
|
| 2008 |
Piu F, Cheevers C, Hyldtoft L, Gardell LR, Del Tredici AL, Andersen CB, Fairbairn LC, Lund BW, Gustafsson M, Schiffer HH, Donello JE, Olsson R, Gil DW, Brann MR. Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist. European Journal of Pharmacology. 590: 423-9. PMID 18559275 DOI: 10.1016/j.ejphar.2008.05.015 |
0.454 |
|
| 2007 |
Ossipov MH, Bazov I, Gardell LR, Kowal J, Yakovleva T, Usynin I, Ekström TJ, Porreca F, Bakalkin G. Control of chronic pain by the ubiquitin proteasome system in the spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8226-37. PMID 17670969 DOI: 10.1523/Jneurosci.5126-06.2007 |
0.71 |
|
| 2007 |
Piu F, Hyldtoft L, Gardell L, Cheevers C, Tredici A, Andersen C, Fairbain L, Lund B, Gustafsson M, Gil D, Bonhaus D, Olsson R. 392 A SELECTIVE ESTROGEN RECEPTOR BETA AGONIST MODULATES NEUROPATHIC AND INFLAMMATORY PAIN STATES European Journal of Pain. 11: S174-S174. DOI: 10.1016/j.ejpain.2007.03.407 |
0.376 |
|
| 2006 |
Lai J, Luo MC, Chen Q, Ma S, Gardell LR, Ossipov MH, Porreca F. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nature Neuroscience. 9: 1534-40. PMID 17115041 DOI: 10.1038/Nn1804 |
0.777 |
|
| 2006 |
Gardell LR, King T, Ossipov MH, Rice KC, Lai J, Vanderah TW, Porreca F. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neuroscience Letters. 396: 44-9. PMID 16343768 DOI: 10.1016/J.Neulet.2005.11.009 |
0.792 |
|
| 2005 |
King T, Gardell LR, Wang R, Vardanyan A, Ossipov MH, Malan TP, Vanderah TW, Hunt SP, Hruby VJ, Lai J, Porreca F. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain. 116: 276-88. PMID 15964684 DOI: 10.1016/J.Pain.2005.04.014 |
0.788 |
|
| 2005 |
Xie JY, Herman DS, Stiller CO, Gardell LR, Ossipov MH, Lai J, Porreca F, Vanderah TW. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 409-16. PMID 15647484 DOI: 10.1523/Jneurosci.4054-04.2005 |
0.795 |
|
| 2004 |
Gardell LR, Ibrahim M, Wang R, Wang Z, Ossipov MH, Malan TP, Porreca F, Lai J. Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic pain. Neuroscience. 123: 43-52. PMID 14667440 DOI: 10.1016/J.Neuroscience.2003.08.021 |
0.756 |
|
| 2003 |
Gardell LR, Wang R, Ehrenfels C, Ossipov MH, Rossomando AJ, Miller S, Buckley C, Cai AK, Tse A, Foley SF, Gong B, Walus L, Carmillo P, Worley D, Huang C, et al. Multiple actions of systemic artemin in experimental neuropathy. Nature Medicine. 9: 1383-9. PMID 14528299 DOI: 10.1038/Nm944 |
0.753 |
|
| 2003 |
Dogrul A, Gardell LR, Ossipov MH, Tulunay FC, Lai J, Porreca F. Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain. 105: 159-68. PMID 14499432 DOI: 10.1016/S0304-3959(03)00177-5 |
0.615 |
|
| 2003 |
Gardell LR, Vanderah TW, Gardell SE, Wang R, Ossipov MH, Lai J, Porreca F. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8370-9. PMID 12967999 DOI: 10.1523/Jneurosci.23-23-08370.2003 |
0.774 |
|
| 2002 |
Gardell LR, Ossipov MH, Vanderah TW, Lai J, Porreca F. Dynorphin-independent spinal cannabinoid antinociception. Pain. 100: 243-8. PMID 12467995 DOI: 10.1016/S0304-3959(02)00173-2 |
0.755 |
|
| 2002 |
Dogrul A, Gardell LR, Ma S, Ossipov MH, Porreca F, Lai J. 'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice. Pain. 100: 203-9. PMID 12435473 DOI: 10.1016/S0304-3959(02)00302-0 |
0.713 |
|
| 2002 |
Ossipov MH, Zhang ET, Carvajal C, Gardell L, Quirion R, Dumont Y, Lai J, Porreca F. Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 9858-67. PMID 12427842 DOI: 10.1523/Jneurosci.22-22-09858.2002 |
0.558 |
|
| 2002 |
Gardell LR, Wang R, Burgess SE, Ossipov MH, Vanderah TW, Malan TP, Lai J, Porreca F. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6747-55. PMID 12151554 DOI: 10.1523/Jneurosci.22-15-06747.2002 |
0.794 |
|
| 2002 |
Gardell LR, Burgess SE, Dogrul A, Ossipov MH, Malan TP, Lai J, Porreca F. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance. Pain. 98: 79-88. PMID 12098619 DOI: 10.1016/S0304-3959(01)00475-4 |
0.756 |
|
| 2002 |
Burgess SE, Gardell LR, Ossipov MH, Malan TP, Vanderah TW, Lai J, Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5129-36. PMID 12077208 DOI: 10.1523/Jneurosci.22-12-05129.2002 |
0.781 |
|
| 2001 |
Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan TP, Ossipov MH, Lappi DA, Lai J. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5281-8. PMID 11438603 DOI: 10.1523/Jneurosci.21-14-05281.2001 |
0.793 |
|
| 2001 |
Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U, Hruby VJ, Malan TP, Lai J, Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 1779-86. PMID 11222667 DOI: 10.1523/Jneurosci.21-05-01779.2001 |
0.762 |
|
| 2000 |
Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Zhong CM, Zhang ET, Malan TP, Ossipov MH, Lai J, Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 7074-9. PMID 10995854 DOI: 10.1523/Jneurosci.20-18-07074.2000 |
0.803 |
|
| 2000 |
Malan TP, Ossipov MH, Gardell LR, Ibrahim M, Bian D, Lai J, Porreca F. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain. 86: 185-94. PMID 10779675 DOI: 10.1016/S0304-3959(00)00243-8 |
0.768 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2009 |
Gaubert G, Bertozzi F, Kelly NM, Pawlas J, Scully AL, Nash NR, Gardell LR, Lameh J, Olsson R. Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists. Journal of Medicinal Chemistry. 52: 6511-4. PMID 19803524 DOI: 10.1021/jm9011998 |
0.291 |
|
| 2008 |
Gardell LR, Ma JN, Seitzberg JG, Knapp AE, Schiffer HH, Tabatabaei A, Davis CN, Owens M, Clemons B, Wong KK, Lund B, Nash NR, Gao Y, Lameh J, Schmelzer K, et al. Identification and characterization of novel small-molecule protease-activated receptor 2 agonists. The Journal of Pharmacology and Experimental Therapeutics. 327: 799-808. PMID 18768780 DOI: 10.1124/jpet.108.142570 |
0.229 |
|
| 2007 |
Ma JN, Schiffer HH, Knapp AE, Wang J, Wong KK, Currier EA, Owens M, Nash NR, Gardell LR, Brann MR, Olsson R, Burstein ES. Identification of the atypical L-type Ca2+ channel blocker diltiazem and its metabolites as ghrelin receptor agonists. Molecular Pharmacology. 72: 380-6. PMID 17475811 DOI: 10.1124/mol.107.034298 |
0.203 |
|
| 2007 |
Gardell LR, Vanover KE, Pounds L, Johnson RW, Barido R, Anderson GT, Veinbergs I, Dyssegaard A, Brunmark P, Tabatabaei A, Davis RE, Brann MR, Hacksell U, Bonhaus DW. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models. The Journal of Pharmacology and Experimental Therapeutics. 322: 862-70. PMID 17519387 DOI: 10.1124/jpet.107.121715 |
0.195 |
|
| 2006 |
Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J, Del Tredici AL, Piu F, Schiffer HH, Ott TR, Burstein ES, Uldam AK, Thygesen MB, Schlienger N, Andersson CM, et al. Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist. The Journal of Pharmacology and Experimental Therapeutics. 317: 910-8. PMID 16469866 DOI: 10.1124/Jpet.105.097006 |
0.192 |
|
| 2008 |
Piu F, Gardell LR, Son T, Schlienger N, Lund BW, Schiffer HH, Vanover KE, Davis RE, Olsson R, Bradley SR. Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator. The Journal of Steroid Biochemistry and Molecular Biology. 109: 129-37. PMID 18164613 DOI: 10.1016/j.jsbmb.2007.11.001 |
0.183 |
|
| 2009 |
Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, et al. Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists. Journal of Medicinal Chemistry. 52: 1975-82. PMID 19338356 DOI: 10.1021/jm801534c |
0.158 |
|
| 2009 |
Schlienger N, Lund BW, Pawlas J, Badalassi F, Bertozzi F, Lewinsky R, Fejzic A, Thygesen MB, Tabatabaei A, Bradley SR, Gardell LR, Piu F, Olsson R. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators. Journal of Medicinal Chemistry. 52: 7186-91. PMID 19856921 DOI: 10.1021/jm901149c |
0.158 |
|
| 2008 |
Acevedo S, Gardell L, Bradley SR, Piu F, Raber J. Selective androgen receptor modulators antagonize apolipoprotein E4-induced cognitive impairments Letters in Drug Design and Discovery. 5: 271-276. DOI: 10.2174/157018008784619898 |
0.154 |
|
| 1998 |
Cramer CM, Gardell LR, Boedeker KL, Harris JR, Hubbell CL, Reid LD. Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol. Pharmacology, Biochemistry, and Behavior. 60: 345-56. PMID 9632216 DOI: 10.1016/S0091-3057(97)00593-5 |
0.126 |
|
| 1997 |
Gardell LR, Reid LD, Boedeker KL, Liakos TM, Hubbell CL. Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Alcoholism, Clinical and Experimental Research. 21: 1592-8. PMID 9438517 |
0.122 |
|
| 1996 |
Reid LD, Gardell LR, Chattopadhyay S, Hubbell CL. Periodic naltrexone and propensity to take alcoholic beverage. Alcoholism, Clinical and Experimental Research. 20: 1329-34. PMID 8947306 |
0.114 |
|
| 1997 |
Gardell LR, Whalen CA, Chattophadyay S, Cavallaro CA, Hubbell CL, Reid LD. Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage. Alcoholism, Clinical and Experimental Research. 21: 1435-9. PMID 9394115 |
0.103 |
|
| 1998 |
Gardell LR, Whalen CA, Chambers MD, Boswell KJ, Hubbell CL, Reid LD. Valproate reduces intake of alcoholic beverage among rats. Behavioural Pharmacology. 9: 683-9. PMID 9890258 DOI: 10.1097/00008877-199812000-00004 |
0.094 |
|
| 1996 |
Gardell LR, Hubbell CL, Reid LD. Naltrexone persistently reduces rats' intake of a palatable alcoholic beverage. Alcoholism, Clinical and Experimental Research. 20: 584-8. PMID 8727259 |
0.09 |
|
| 1999 |
Gardell LR, Reid ML, Cavallero CA, Burgess SE, Wallace RF, Hubbell CL, Reid LD. Amlodipine, a calcium channel inhibitor, and cocaine and ethanol's reinforcing effects. Pharmacology, Biochemistry, and Behavior. 64: 567-72. PMID 10548273 DOI: 10.1016/S0091-3057(99)00129-X |
0.082 |
|
| Hide low-probability matches. |